GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » R1 RCM Inc (FRA:6HL0) » Definitions » Research & Development

R1 RCM (FRA:6HL0) Research & Development : €0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is R1 RCM Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. R1 RCM's Research & Development for the three months ended in Mar. 2024 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

R1 RCM Research & Development Historical Data

The historical data trend for R1 RCM's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R1 RCM Research & Development Chart

R1 RCM Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

R1 RCM Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

R1 RCM Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

R1 RCM  (FRA:6HL0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

R1 RCM Research & Development Related Terms

Thank you for viewing the detailed overview of R1 RCM's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

R1 RCM (FRA:6HL0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » R1 RCM Inc (FRA:6HL0) » Definitions » Research & Development
Comparable Companies
TXG DOCS HQY PGNY EVH TDOC PRVA PINC GDRX CERT VEEV GEHC TSE:2413 ASX:PME HKSE:01833 SZSE:300253 TSE:4483 NXGN OMCL SZSE:300451
Traded in Other Exchanges
RCM:USA
Address
434 West Ascension Way, 6th Floor, Murray, UT, USA, 84123
Website
https://www.r1rcm.com
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.

R1 RCM (FRA:6HL0) Headlines

No Headlines